me": "353", "year": "2006"}, "text": "Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease", "sentences": [], "annotations": [], "relations": []}, {"offset": 40149, "infons": {"fpage": "511", "lpage": "20", "name_0": "surname:Vollmer;given-names:TL", "name_1": "surname:Phillips;given-names:JT", "name_2": "surname:Goodman;given-names:AD", "pub-id_pmid": "15471366", "section_type": "REF", "source": "Mult Scler", "type": "ref", "volume": "10", "year": "2004"}, "text": "An open-label safety and drug interaction study of natalizumab (Antegren ) in combination with interferon-beta (Avonex ) in patients with multiple sclerosis", "sentences": [], "annotations": [], "relations": []}, {"offset": 40309, "infons": {"fpage": "473", "lpage": "83", "name_0": "surname:Ware;given-names:JE", "name_1": "surname:Sherbourne;given-names:CD", "pub-id_pmid": "1593914", "section_type": "REF", "source": "Med Care", "type": "ref", "volume": "6", "year": "1992"}, "text": "The MOS 36-item Short-Form Health Survey (SF-36).